Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Glioblastoma

Not yet recruiting

Registered drugNo placebo

Study of NMS-03305293 and Temozolomide for Adults with Recurrent Glioblastoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Nms-03305293

Contact Research Centre

Glioblastoma+1

Not recruiting

InvestigationalNo placebo

Study on the Safety of Photodynamic Therapy with Aminolevulinic Acid Hydrochloride for Patients Aged 18-75 with Grade IV Glioblastoma

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Aminolevulinic Acid Hydrochloride

Contact Research Centre

Glioblastoma

Not recruiting

Registered drug

Study on the Effectiveness of Optune with Temozolomide and Pembrolizumab in Patients with Newly Diagnosed Glioblastoma

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Glioblastoma

Not recruiting

InvestigationalNo placebo

Study of AGuIX Nanoparticles and Temozolomide with Radiotherapy for Patients with Newly Diagnosed Glioblastoma

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years

Contact Research Centre

Glioblastoma

Not recruiting

Registered drugNo placebo

Study on the Effects of Doxorubicin and Temozolomide After Radiotherapy in Children and Young Adults with Glioblastoma

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years
Substances:Temozolomide

Contact Research Centre

Glioblastoma

Not recruiting

Registered drugNo placebo

Study on Durvalumab and Radiation Therapy for Patients with Recurrent Glioblastoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Glioblastoma

Not recruiting

InvestigationalNo placebo

Study on the Effectiveness and Safety of a Vaccine with Dendritic Cells for Patients with Newly Diagnosed Glioblastoma

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Autologous Mature Dendritic Cells Loaded With Autologous Tumor Lysate

Contact Research Centre

Glioblastoma+1

Not recruiting

Registered drugNo placebo

Study on the Effects of Losartan Potassium on Brain Tumors in Patients with Glioblastoma or Brain Metastases from Non-Small-Cell Lung Cancer

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Losartan Potassium

Contact Research Centre

Glioblastoma+2

Not recruiting

Registered drugNo placebo

Study on the Safety of Aminolevulinic Acid with Ultrasound Therapy for Patients with Newly Diagnosed High-Grade Glioma Before Surgery and Standard Treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Aminolevulinic Acid Hydrochloride

Contact Research Centre

Glioblastoma

Not recruiting

InvestigationalNo placebo

Study on WT1 LAMP mRNA DC and Temozolomide for Patients with Newly Diagnosed Glioblastoma

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Wt1 Lamp Mrna Dc

Contact Research Centre

Glioblastoma

Not recruiting

Registered drug

Study on the Safety and Effectiveness of 2-Hydroxyoleic Acid and Temozolomide with Radiotherapy for Patients with Newly Diagnosed Glioblastoma

Registered drug

France

Participants:18–64 years · 65+ years
Substances:IDROXIOLEIC ACID

Contact Research Centre

Glioblastoma+4

Not recruiting

Registered drugNo placebo

Study on Ribociclib, Topotecan, and Temozolomide for Children and Young Adults (12 months - 21 years) with Relapsed or Refractory Neuroblastoma and Solid Tumors

Registered drugNo placebo

Czechia

Participants:0–17 years · 18–64 years
Substances:Ribociclib

Contact Research Centre

Find therapies in clinical trials near you – page 3

40 trials match your criteria

Glioblastoma

Study of NMS-03305293 and Temozolomide for Adults with Recurrent Glioblastoma

Glioblastoma+1

Study on the Safety of Photodynamic Therapy with Aminolevulinic Acid Hydrochloride for Patients Aged 18-75 with Grade IV Glioblastoma

Glioblastoma

Study on the Effectiveness of Optune with Temozolomide and Pembrolizumab in Patients with Newly Diagnosed Glioblastoma

Glioblastoma

Study of AGuIX Nanoparticles and Temozolomide with Radiotherapy for Patients with Newly Diagnosed Glioblastoma

Glioblastoma

Study on the Effects of Doxorubicin and Temozolomide After Radiotherapy in Children and Young Adults with Glioblastoma

Glioblastoma

Study on Durvalumab and Radiation Therapy for Patients with Recurrent Glioblastoma

Glioblastoma

Study on the Effectiveness and Safety of a Vaccine with Dendritic Cells for Patients with Newly Diagnosed Glioblastoma

Glioblastoma+1

Study on the Effects of Losartan Potassium on Brain Tumors in Patients with Glioblastoma or Brain Metastases from Non-Small-Cell Lung Cancer

Glioblastoma+2

Study on the Safety of Aminolevulinic Acid with Ultrasound Therapy for Patients with Newly Diagnosed High-Grade Glioma Before Surgery and Standard Treatment

Glioblastoma

Study on WT1 LAMP mRNA DC and Temozolomide for Patients with Newly Diagnosed Glioblastoma

Glioblastoma

Study on the Safety and Effectiveness of 2-Hydroxyoleic Acid and Temozolomide with Radiotherapy for Patients with Newly Diagnosed Glioblastoma

Glioblastoma+4

Study on Ribociclib, Topotecan, and Temozolomide for Children and Young Adults (12 months - 21 years) with Relapsed or Refractory Neuroblastoma and Solid Tumors

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.